The combination regimen proved better than monotherapy in bacteremias ( adr , 32.8 % ; 95 % CI , 19 % to 46 % ; P < .001 ) and in clinically documented infections ( adr , 36 % ; 95 % CI , 9 % to 64 % ; P < .01 ) .